2.5000
-0.2500
(-9.09%)
At close: January 10 at 4:11:23 PM GMT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Che J. Connon | CEO, MD & Executive Director | 109.73k | -- | 1972 |
| Mr. Geoffrey Robert Baker B.Com., L.L.B., LL.B., M.B.A., MBA | Company Secretary & Non-Executive Director | 47.5k | -- | 1956 |
| Mr. Graham John William Duncan | Chief Financial Officer | -- | -- | 1963 |
| Mr. Ricardo Gouveia | C.S.O | -- | -- | -- |
| Mr. Marcelo Bravo | Chief Business Officer | -- | -- | -- |
BSF Enterprise Plc
Aldgate Tower
2 Leman Street
London, E1 8QN
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 12
Description
BSF Enterprise Plc does not have significant operations. The company intends to acquire the businesses within biotechnology, innovative marketing, and e-commerce sectors. BSF Enterprise Plc was incorporated in 2018 and is based in London, United Kingdom.
Corporate Governance
BSF Enterprise Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
PBDA.DU Protalix BioTherapeutics Inc
2.1150
-1.90%
SCLP.L Scancell Holdings plc
10.10
+3.59%
AVCT.L Avacta Group Plc
51.00
0.00%
RPTX Repare Therapeutics Inc.
1.3800
+7.81%
KPTI Karyopharm Therapeutics Inc.
0.7186
+0.36%
BCAB BioAtla, Inc.
0.5316
-5.07%
TLSA Tiziana Life Sciences Ltd
0.8400
+14.13%
MRSN Mersana Therapeutics, Inc.
0.7200
-44.62%
FGEN FibroGen, Inc.
0.6160
-5.35%
PLX Protalix BioTherapeutics, Inc.
2.2700
0.00%